Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (22)

2024

  1. Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

2013

  1. Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis

    Journal of Immunology, Vol. 191, Núm. 5, pp. 2144-2154

  2. Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation

    PLoS ONE, Vol. 8, Núm. 11

2010

  1. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 1, pp. 241-248

  2. Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels

    Molecular and Cellular Biology, Vol. 30, Núm. 10, pp. 2537-2551

2009

  1. Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles

    Nanomedicine, Vol. 4, Núm. 8, pp. 919-930

  2. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

    Gut, Vol. 58, Núm. 7, pp. 929-939

  3. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide

    Journal of Immunology, Vol. 183, Núm. 7, pp. 4346-4359

  4. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

    Arthritis and Rheumatism, Vol. 60, Núm. 4, pp. 1006-1019

2008

  1. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders

    Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 135-140

  2. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019

  3. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037

  4. Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels

    GLIA, Vol. 56, Núm. 10, pp. 1091-1103

2007

  1. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

    Trends in Pharmacological Sciences, Vol. 28, Núm. 9, pp. 482-491

  2. Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy

    Annals of the Rheumatic Diseases

  3. Regulation of immune tolerance by anti-inflammatory neuropeptides

    Nature Reviews Immunology, Vol. 7, Núm. 1, pp. 52-63

  4. Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders

    Peptides, Vol. 28, Núm. 9, pp. 1833-1846

  5. Tuning inflammation with anti-inflammatory neuropeptides

    Expert Opinion on Biological Therapy, Vol. 7, Núm. 4, pp. 461-478

  6. Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis

    Trends in Molecular Medicine, Vol. 13, Núm. 6, pp. 241-251

2006

  1. Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice

    Annals of the New York Academy of Sciences